Understanding how a specific enzyme contributes to nerve damage in diabetic eye disease.
Mechanisms of neurodegeneration in diabetic retinopathy: Role of spermine oxidase
This study is looking at how a specific enzyme called spermine oxidase might be linked to nerve damage in people with diabetic retinopathy, and by understanding its role, the researchers hope to find new ways to help protect your eyesight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-10610809 on NIH RePORTER |
What this research studies
This research investigates the role of spermine oxidase, an enzyme involved in the metabolism of polyamines, in causing nerve damage associated with diabetic retinopathy (DR). By studying how this enzyme is regulated in diabetic conditions, the researchers aim to uncover the molecular mechanisms that lead to neuronal dysfunction in the retina. The approach includes experimental models to manipulate spermine oxidase levels and assess the resulting effects on retinal neurons. This could lead to new therapeutic strategies to prevent or slow the progression of DR.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have diabetes and are at risk for or experiencing diabetic retinopathy.
Not a fit: Patients without diabetes or those who do not have diabetic retinopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent vision loss in patients with diabetic retinopathy.
How similar studies have performed: Previous research has shown that targeting specific enzymes involved in neurodegeneration can lead to significant improvements in related conditions, suggesting a promising avenue for this approach.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Narayanan, Priya — University of Georgia
- Study coordinator: Narayanan, Priya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.